Details of the Drug Reposition

General Information of This Drug (ID: DM6OKBJ)

Drug Name
Ropidoxuridine   DM6OKBJ
Synonyms IPdR; IPdR (LADD), Hana; IPdR, (LADD) SuperGen; 5-iodo-pyrimidinone-2'-deoxyribose; 5-iodo-pyrimidinone-2-deoxyribose (LADD), SuperGen
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [1]
Gastrointestinal cancer DISHIGUN 2C11 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02381561) Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)